Communiqués Bluestar Adisseo Company

Actions

600299

CNE000001253

Produits pharmaceutiques

Cours en clôture Shanghai S.E. 15/09/2026			Varia. 5j.	Varia. 1 janv.
8,300 ^CNY	-2,81%		-3,71%	-7,47%

07/09	Le directeur général adjoint de Bluestar Adisseo sanctionné par le gendarme financier chinois	MT
30/08	Bluestar Adisseo Company publie ses résultats pour le semestre clos le 30 juin 2026	CI

Communiqués

27/10/23	Q3 2023: Signs of rebound in gross profit driven by continuous liquid methionine volume growth and proactive cost management	PU
07/08/23	Bluestar Adisseo : H1 result estimated landing around CNY33.40m despite continued volume growth and cost reduction starting to impact positively	PU
14/07/23	Bluestar Adisseo : H1 result estimated landing around CNY30-35mil despite continued volume growth and cost reduction starting to impact positively	PU
01/07/23	Bluestar Adisseo : Adisseo announces the appointment of Dr HAO Zhigang as Chief Executive Officer to succeed to Jean-Marc Dublanc.	PU
27/02/23	Bluestar Adisseo : Adisseo announces the completion of the acquisition of Nor-Feed	PU
17/12/22	Bluestar Adisseo : Adisseo announces the signing of an agreement for the acquisition of Nor-Feed and positions itself on a new range of sustainable and natural specialty ingredients for Animal Nutrition	PU
28/10/22	Q3 2022: continuous growth in revenues, margins negatively impacted by steep cost increase in Q3 Implementation of action plans to protect margins	PU
15/09/22	Bluestar Adisseo : 180,000-ton-per-year Liquid Methionine Project Goes into Operation	PU
29/07/22	Bluestar Adisseo : Continued growth in revenue (+20%) and net profit (+6.5%) despite challenging macro-environment	PU
01/07/22	Bluestar Adisseo : First industrial-scale FeedKind® facility heralds new era of food security for China	PU
21/04/22	Bluestar Adisseo : Adisseo Provides Stable Support for Pandemic Prevention and Product Supply	PU
15/03/22	Bluestar Adisseo : Adisseo Operation in Europe Fully Sustained	PU
17/02/22	FY2021: Solid growth in sales and net profit contributed to shareholders in a volatile and challenging context	PU
06/01/22	Bluestar Adisseo : Chairman Hao Zhigang Shared Adisseo Case with CEIBS GEMBA Students	PU
23/12/21	Bluestar Adisseo : Adisseo Awarded“2021 Annual Outstanding Practice Case of Office of Board of Directors of Public Companies”	PU
03/12/21	Bluestar Adisseo : Adisseo's methionine plant in China celebrates its first 1 million tonnes	PU
11/11/21	Hao Zhigang, Chairman of Bluestar Adisseo, met with Liu Lei, Secretary of the Party Committee and Executive Vice Chairman of CAPCO	PU
29/10/21	Q3 2021: Double-digit growth in revenues and net profit	PU
27/04/21	Bluestar Adisseo : Annual Shareholders' Meeting for FY2020 - Meeting Material	PU
01/04/21	Bluestar Adisseo : 2021-012 Announcement on Obtaining the Approval of the Joint Restructuring of SinoChem Group and ChemChina	PU
01/04/21	Bluestar Adisseo : Adisseo 5-years Ambition	PU
31/03/21	Bluestar Adisseo : Audit, Risk and Compliance Committee's Report for FY2020	PU
31/03/21	Bluestar Adisseo : Internal Control Assessment Report of 2020	PU
31/03/21	Bluestar Adisseo : 2021-008 Announcement on Renewal of the Financial Services with ChemChina Finance Co., Ltd	PU
31/03/21	Bluestar Adisseo : 2021-009 Announcement on Change of Accounting Policies	PU